Daniel D. Joyce, MD, MS
Medical School: Mayo Medical School
Residency: Vanderbilt University Medical Center
Fellowship: Mayo Clinic, Rochester MN
Clinical Interests: Kidney Cancer, Testis Cancer, Bladder Cancer, Prostate cancer, Genitourinary cancer
Dr. Joyce is a urologic oncologist and assistant professor in the Department of Urology at Vanderbilt University Medical Center specializing in the surgical management of complex genitourinary cancers. He completed a Society of Urologic Oncology fellowship and earned a master’s degree with a concentration in healthcare delivery at the Mayo Clinic in Rochester, Minn., where he also attended medical school. He received a Bachelor of Fine Arts with honors from New York University and completed his urology residency at Vanderbilt University Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society and has held multiple national leadership roles, including service on the Society of Urologic Oncology Fellowship Committee, the American Urological Association Southeastern Section Bylaws Committee, and the National Comprehensive Cancer Network Testicular Cancer Guidelines Panel. He previously served as an editor for The Journal of Urology and as the Southeastern Section representative for the American Urological Association Residents and Fellows Committee.
Clinical Interests
Dr. Joyce offers the full spectrum of contemporary urologic oncology surgery, including advanced robotic, single-port robotic and complex open surgical procedures for kidney, testicular, bladder, prostate and adrenal genitourinary malignancies.
His practice is particularly focused on kidney and testicular cancers, especially highly complex cases requiring advanced surgical planning and multidisciplinary care. He performs cutting-edge, minimally invasive procedures such as single-port robotic partial nephrectomy while also maintaining expertise in major open oncologic operations, including retroperitoneal lymph node dissection and inferior vena cava tumor thrombus surgery for advanced renal cell carcinoma. Patients are frequently referred to him for technically challenging kidney masses, advanced testicular cancer and locally advanced genitourinary malignancies.
In addition to his surgical practice, Dr. Joyce is an active health services and outcomes researcher whose work focuses on improving the value of cancer care, reducing financial toxicity for patients and integrating patient-reported outcomes into clinical decision-making. His research has examined comparative effectiveness, healthcare policy, cost-effectiveness of cancer therapies and shared decision-making in urologic oncology. He has authored numerous peer-reviewed publications and national presentations related to health care value, cancer outcomes, health care economics and patient-centered cancer care.
Dr. Joyce maintains an active national presence in academic urology and health care policy discussions, contributing to initiatives focused on improving cancer care delivery, transparency and physician-patient communication. His work seeks to combine surgical excellence, patient-centered care, health care economics and emerging technologies to improve outcomes and decision-making for patients with genitourinary cancers.